---
figid: PMC8126031__ijms-22-05019-g003
figtitle: Lessons to Learn for Adequate Targeted Therapy Development in Metastatic
  Colorectal Cancer Patients
organisms:
- Homo sapiens
- Mus musculus
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC8126031
filename: ijms-22-05019-g003.jpg
figlink: /pmc/articles/PMC8126031/figure/ijms-22-05019-f003/
number: F3
caption: Schematic diagram of the IGF1R pathway. IGF1R phosphorylates the scaffold
  proteins IRS1 and can bind both PI3K (via the p85 subunit of PI3K) and the GRB2-SOS
  complex. PI3K activates downstream signaling (AKT, MTOR), whereas GRB-SOS stimulates
  RAS to activate the MAPK pathway (RAF/MEK/ERK). Both pathways can stimulate transcription
  factors such as c-Myc, c-Fos, and c-Jun to promote cell survival, proliferation,
  invasion, and metastasis. IGF1R crosstalks with integrins and RACK1 and FAK proteins
  and promotes cell migration. In addition, IGF1R SUMOylation and EMT can also contribute
  to proliferation and apoptotic resistance. Interaction with other RTKs such as HER2,
  MET, and EGFR constitutes an alternative IGF1R pathway. Finally, IGF1R signaling
  can also promote an immunosuppressive tumor microenvironment.
papertitle: Lessons to Learn for Adequate Targeted Therapy Development in Metastatic
  Colorectal Cancer Patients.
reftext: Helena Oliveres, et al. Int J Mol Sci. 2021 May;22(9):5019.
year: '2021'
doi: 10.3390/ijms22095019
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords: insulin-like growth factor receptor | metastatic colorectal cancer
automl_pathway: 0.954108
figid_alias: PMC8126031__F3
figtype: Figure
redirect_from: /figures/PMC8126031__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8126031__ijms-22-05019-g003.html
  '@type': Dataset
  description: Schematic diagram of the IGF1R pathway. IGF1R phosphorylates the scaffold
    proteins IRS1 and can bind both PI3K (via the p85 subunit of PI3K) and the GRB2-SOS
    complex. PI3K activates downstream signaling (AKT, MTOR), whereas GRB-SOS stimulates
    RAS to activate the MAPK pathway (RAF/MEK/ERK). Both pathways can stimulate transcription
    factors such as c-Myc, c-Fos, and c-Jun to promote cell survival, proliferation,
    invasion, and metastasis. IGF1R crosstalks with integrins and RACK1 and FAK proteins
    and promotes cell migration. In addition, IGF1R SUMOylation and EMT can also contribute
    to proliferation and apoptotic resistance. Interaction with other RTKs such as
    HER2, MET, and EGFR constitutes an alternative IGF1R pathway. Finally, IGF1R signaling
    can also promote an immunosuppressive tumor microenvironment.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Zeb2
  - Zeb1
  - Erbb2
  - Snai1
  - Snai2
  - Itk
  - Slc22a3
  - Pik3r1
  - Car2
  - Irs1
  - Akt1
  - Mtor
  - Igf1r
  - Shc1
  - ras
  - Hras
  - Kras
  - Rem1
  - Mdk
  - Ephb2
  - Mapk1
  - Caf
  - Nanog
  - Stat3
  - Tme
  - ZEB2
  - ZEB1
  - DHH
  - IHH
  - SHH
  - NOTCH1
  - NOTCH2
  - NOTCH3
  - NOTCH4
  - ERBB2
  - SNAI1
  - SNAI2
  - IGFBP1
  - IGFBP2
  - IGFBP3
  - IGFBP4
  - IGFBP5
  - IGFBP6
  - IGFBP7
  - ITK
  - SLC22A3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - CA2
  - IRS1
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - IGF1R
  - SHC1
  - SHC2
  - SHC3
  - SHC4
  - KRAS
  - HRAS
  - NRAS
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - XYLT2
  - SOS1
  - SOS2
  - KAT2B
  - TAM
  - STIM1
  - NANOG
  - STAT3
  - .na.character
  - we
  - sna
  - Sumo
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - Tor
  - Shc
  - Ras64B
  - Ras85D
  - Dsor1
  - Mtk
  - Erk7
  - rl
  - Sos
  - rack
  - Acf
  - PolG1
  - pyd
---
